Lifestyle Interventions Based on the Mediterranean Diet for Patients With Rheumatoid Arthritis

January 4, 2014 updated by: M. Yannakoulia, Harokopio University

Lifestyle Interventions Based on the Mediterranean Diet for Patients With Rheumatoid Arthritis: a Randomized Controlled Trial

Aim of the present study was to evaluate the effect of different lifestyle intervention administrations, in increasing adherence to the Mediterranean diet in a group of patients with RA living in the Mediterranean basin, and, thus, in improving parameters related to subjective and objective disease markers, including plasma adiponectin concentrations.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The effect of various dietary regimens and nutrient supplementation on rheumatoid arthritis (RA) has been previously explored, with the majority of the evidence supporting the beneficial effect of n-3 polyunsaturated fatty acids (PUFAs), consumed mainly as fish oil supplements. However, many capsules should be taken on a daily basis (10 - 15) in order to improve health status, increasing, thus, the high drug burden these patients may encounter; inability to comply with supplementation, as depicted in drop-out rates and adverse reactions, is also of concern. On the other hand, the so far investigation of specific dietary patterns, namely elemental or vegetarian diets, revealed similar limitations regarding inability to comply, without producing clear benefit.

The last decade, a traditional dietary pattern, the Mediterranean diet, has also been investigated in patients with RA. This pattern is characterized by abundance of plant foods (fruits, mainly as typical daily desserts, vegetables, bread, other forms of cereals, beans, nuts, and seeds), olive oil as the principal source of fat, moderate amounts of dairy products (mainly cheese and yogurt), low to moderate amounts of fish and poultry, red meat in low amounts and wine consumed in moderation, normally with meals. Adherence to the Mediterranean diet has been associated with a significant reduction in total mortality and improvement in longevity, as well as with lower incidence of atherosclerosis, coronary heart disease, metabolic syndrome and biochemical markers related to insulin resistance and inflammation. In RA, in specific, it has been shown to improve objective and subjective measures. It is also worth mentioning that this type of intervention produced negligible or no adverse effects or drop-out in RA patients. However, it has been implemented in North-European populations with a background diet far away from the Mediterranean dietary habits. It would be interesting to study the effect of a Mediterranean diet-based intervention in a Mediterranean population of RA patients, evaluate their adherence and changes in subjective disease measures as well as in biochemical markers. One of the markers of interest is adiponectin, a large 30-kDa protein produced mainly by adipocytes, sharing strong homologies with TNF and the complement factor C1q. Plasma levels of adiponectin have been negatively associated with indices of obesity, insulin resistance and cardiovascular disease. However, its role in RA is still controversial with some evidence indicating a proinflammatory effect and some other suggesting antiinflammatory properties of this adipocytokine.

Aim of the present study was to evaluate the effect of different lifestyle intervention administrations, in increasing adherence to the Mediterranean diet in a group of patients with RA living in the Mediterranean basin, and, thus, in improving parameters related to subjective and objective disease markers, including plasma adiponectin concentrations.

Study Type

Interventional

Enrollment (Actual)

48

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Athens, Greece, 11521
        • Euroclinic Private Hopsital
      • Athens, Greece, 15773
        • Laiko General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • adults
  • rheumatoid arthritis diagnosis according to the 1987 criteria of the American College of Rheumatology
  • clinically non active disease, as assessed and documented by the patient's own rheumatology specialist

Exclusion Criteria:

  • being on a slimming or any other special diet during the previous year, or being diagnosed with other serious medical conditions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Face-to-face
Patients received face-to-face nutrition counseling.
Patients received nutrition counseling, through one-to-one sessions conducted once a month, until the 6-month evaluation. Nutrition counseling was based on goal-setting and aimed at increasing adherence to Mediterannean diet.
Experimental: Telephone
Patients received telephone nutrition counseling.
Patients received nutrition counseling, through one-to-one sessions conducted once a month, until the 6-month evaluation. Nutrition counseling was based on goal-setting and aimed at increasing adherence to Mediterannean diet.
No Intervention: Minimum Intervention
Patients in this group received no further lifestyle-related counseling and contact until the 6-month evaluation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Age
Time Frame: baseline
baseline
Change from baseline Mediterranean Diet Score at 6 months
Time Frame: 6 months
6 months
Change from baseline Disease Activity Score (DAS28) at 6 months
Time Frame: 6 months
6 months
Change from baseline Health Assessment Questionnaire (HAQ) Score at 6 months
Time Frame: 6 months
6 months
Change from baseline Short Form-36 Health Survey (SF-36) score at 6 months
Time Frame: 6 months
6 months
Change from baseline energy intake at 6 months
Time Frame: 6 months
6 months
Change from baseline in macronutrients intake at 6 months
Time Frame: 6 months
6 months
Height
Time Frame: baseline
baseline
Change from baseline body weight at 6 months
Time Frame: 6 months
6 months
Change from baseline systolic blood pressure at 6 months
Time Frame: 6 months
6 months
Change from baseline plasma adiponectin concentrations at 6 months
Time Frame: 6 months
6 months
Change from baseline plasma glucose levels at 6 months
Time Frame: 6 months
6 months
Change from baseline serum triglycerides levels at 6 months
Time Frame: 6 months
6 months
Change from baseline plasma HDL-cholesterol levels at 6 months
Time Frame: 6 months
6 months
Years of education
Time Frame: baseline
baseline
Change from baseline diastolic blood pressure at 6 months
Time Frame: 6 months
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Mary Yannakoulia, PhD, Harokopio University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2009

Primary Completion (Actual)

July 1, 2011

Study Completion (Actual)

July 1, 2011

Study Registration Dates

First Submitted

January 1, 2014

First Submitted That Met QC Criteria

January 4, 2014

First Posted (Estimate)

January 7, 2014

Study Record Updates

Last Update Posted (Estimate)

January 7, 2014

Last Update Submitted That Met QC Criteria

January 4, 2014

Last Verified

January 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rheumatoid Arthritis

Clinical Trials on Nutrition counseling

3
Subscribe